Cargando…
Retinal degeneration in mice and humans with neuronal ceroid lipofuscinosis type 8
BACKGROUND: Ceroid lipofuscinosis type 8 belongs to a heterogenous group of vision and life-threatening neurodegenerative diseases, neuronal ceroid lipofuscinosis (NCL). Effective therapy is limited to a single drug for treatment of ceroid lipofuscinosis type 2, necessitating animal disease models t...
Autores principales: | Salpeter, Elyse M., Leonard, Brian C., Lopez, Antonio J., Murphy, Christopher J., Thomasy, Sara, Imai, Denise M., Grimsrud, Kristin, Lloyd, K. C. Kent, Yan, Jiong, Sanchez Russo, Rossana, Shankar, Suma P., Moshiri, Ala |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421982/ https://www.ncbi.nlm.nih.gov/pubmed/34532411 http://dx.doi.org/10.21037/atm-20-4739 |
Ejemplares similares
-
Animal models of corneal endothelial dysfunction to facilitate development of novel therapies
por: Park, Sangwan, et al.
Publicado: (2021) -
Advantages of ocular regeneration research
por: Park, Susanna S.
Publicado: (2021) -
Subretinal versus intravitreal administration of human CD34+ bone marrow-derived stem cells in a rat model of inherited retinal degeneration
por: Park, Un Chul, et al.
Publicado: (2021) -
Pluripotent stem cell therapy for retinal diseases
por: Ahmed, Ishrat, et al.
Publicado: (2021) -
Toward a clinical optoretinogram: a review of noninvasive, optical tests of retinal neural function
por: Jonnal, Ravi S.
Publicado: (2021)